Biomedical Excellence for Safer Transfusion
  • Biomedical Excellence for Safer Transfusion (BEST)
    Biomedical Excellence for Safer Transfusion (BEST)

    BEST Collaborative is an international research organization with a vision to lead the field of transfusion medicine and cellular therapies toward the best…

  • BEST Membership
    BEST Membership

    The BEST collaborative is a unique free-standing group of over 170 manufacturers, clinicians, and scientists from 22 countries committed to improving transfusion…

  • BEST Meetings
    BEST Meetings

    BEST meetings are held twice per year. and attendance is open to all members. Invited guests may attend with pre-approval of the Chair.

  • Press Releases
    Press Releases

    Official notices regarding significant publications, special events, and member news.

  • Recommended Procedures
    Recommended Procedures

    Several best practice documents are available for download

  • Sponsorship

    Any commercial organization or Blood Service interested in advancing the purpose of BEST may become a supporter of BEST by paying the annual dues amount; providing a…

Latest News

BEST 30th Anniversary Symposium

Symposium Recording Now Available for Viewing

Call for Scott Murphy Memorial Lecture Applications

Applications for April 2022 are being accepted now thru January 17, 2022

Press Release 13 Oct 2021

Award Recipient of 27th Scott Murphy Memorial Award Lectureship Announced

Member News

  • The BEST 30th Anniversary Symposium was held on Zoom on Saturday November 6th, 2021. The Meeting Recording is now available for viewing. You must complete the access form HERE to obtain the password. 
  • Meeting presentations from BEST 62 in Marina del Rey have been posted in the Members area. Recordings will be available at a later date.
  • In the coming weeks, all BEST Members will be receiving a Non-Disclosure Agreement, which will be required annually going forward. Please contact the BEST Executive Office if you have questions.
  • Please be sure to keep your contact information on the website up to date so you can be assured of receiving our email updates.

Fall 2021

30th Anniversary

BEST 30th Anniversary Celebration Symposium

This symposium was held Saturday, 06 November 2021.
Important Details:

  • The meeting recording is now available. You must complete the access form HERE to obtain the password. 
  • Presentation slides are available to BEST Members only, in the Members area of this website.
  • The Symposium highlighted the past, present, and future of BEST and the Transfusion Medicine industry, as well as the 27th Scott Murphy Memorial Award Lecture.


Spring 2022



The Spring 2022 Meeting is planned for Warsaw, Poland 22-23 April 2022.

Important News

  • We plan to hold the meeting in the Hotel Bristol with the BEST Dinner at the Royal Castle
  • Due to the continuing COVID-19 pandemic, we have no further details at this time.



The Conventional Components Team

The Conventional Components Team of the BEST Collaborative coordinates individual efforts and conducts collaborative international studies that address developmental and regulatory issues regarding the composition and validation of the conventional blood components: red cells, platelets and plasma. Our projects are based principally in the laboratories and blood centers of the BEST members. We perform pilot exploratory studies, inter-laboratory comparisons, and small randomized trials. While principally focused on the methods and needs of advanced blood systems, we have also performed projects suited to countries with emerging economies or even to blood use in field and emergency situations. 

Recent projects from the Conventional Components Team have included:

  • The collaborative development of several new platelet storage solutions.
  • An evaluation of the metabolic effects of holding whole blood at room temperature for up to 26 hours before processing into components
  • A major review of all Cr-51 radioactive red cell recovery studies in the past 15 years to understand the implications of new US FDA standards
  • Development of a flow cytometric method to count platelets
  • Standardization of measurement of platelet activation markers
  • Survey of commercially available blood bags

Current projects include:

  • Comparison and standardization of hemolysis measurement
  • Estimation of the donor effect on various in vitro outcomes
  • Determination of the effect of gamma irradiation on red cell concentrates, and the implication for current guidelines
  • Descriptive survey of current practices of post-production processing steps
  • Evaluation of quality control of pathogen reduction technologies
  • Exploration of the field of non-traditional use of blood components

The Conventional Components Team is working to improve the processing, quality, and utility of conventional blood components.

The team leaders for Conventional Components are Dana Devine, PhD, Chief Medical & Scientific Officer at Canadian Blood Services, Professor of Pathology and Laboratory Medicine at the University of British Columbia and Rebecca Cardigan, PhD, Head of Components Development at NHS Blood and Transplant, Cambridge, UK.